Latest Insights on TOI
Profit From AbbVie’s Struggles Today
February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020. Voting Gets Lazy; Cash-Craving Comcast; Broadcom Bites the Apple
January 24, 2020 Great Stuff
Friday Four Play: The “Getting Lazy” Edition Lazy. The entire country is lazy. We have amazing freedoms in this country … freedoms that are the envy of the world: freedom of speech, freedom of the press, freedom of religion, the right to bear arms, et cetera. But the most important of all? The freedom (and […] Sometimes, It’s Lupus; Sage’s Depressing Results
December 5, 2019 Great Stuff
The Right Prescription for Massive Returns Today, dear readers, we’re going to cover a topic I just know you all love and adore: biotechnology. I can hear the groans already … and I get it. All those big scary words that have no real meaning to you at all. It’s like they’re talking about some […] This Is THE Options Trading Strategy for Earnings Season in 2020
November 15, 2019 American Investor Today, Investing, Stocks
Companies announce their earnings four times a year. Investors speculate on how a stock will move based on earnings — but doing so is a bad habit. With this approach, though, you don’t make a move until after companies report earnings. Anthony Planas talks about this revolutionary strategy that will change how you make money. (3-minute read) Investing for Value or Growth? Don’t Choose 1 … Get Both
October 3, 2019 Investment Opportunities, Stocks, Winning Investor Daily
I encourage you to enjoy the best of both worlds. You can do that by buying this reasonably priced stock that’s growing too.